DE69435244D1 - Verfahren zur übertragung eines biologisch aktiven materials an eine zelle - Google Patents

Verfahren zur übertragung eines biologisch aktiven materials an eine zelle

Info

Publication number
DE69435244D1
DE69435244D1 DE69435244T DE69435244T DE69435244D1 DE 69435244 D1 DE69435244 D1 DE 69435244D1 DE 69435244 T DE69435244 T DE 69435244T DE 69435244 T DE69435244 T DE 69435244T DE 69435244 D1 DE69435244 D1 DE 69435244D1
Authority
DE
Germany
Prior art keywords
transmitting
cell
active material
biologically active
biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69435244T
Other languages
English (en)
Inventor
Donald F H Wallach
Carole Varanelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novavax Inc
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Application granted granted Critical
Publication of DE69435244D1 publication Critical patent/DE69435244D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69435244T 1993-12-17 1994-12-15 Verfahren zur übertragung eines biologisch aktiven materials an eine zelle Expired - Lifetime DE69435244D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16942293A 1993-12-17 1993-12-17
PCT/US1994/014537 WO1995016437A1 (en) 1993-12-17 1994-12-15 Method of transmitting a biologically active material to a cell

Publications (1)

Publication Number Publication Date
DE69435244D1 true DE69435244D1 (de) 2009-11-26

Family

ID=22615617

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69435244T Expired - Lifetime DE69435244D1 (de) 1993-12-17 1994-12-15 Verfahren zur übertragung eines biologisch aktiven materials an eine zelle

Country Status (7)

Country Link
US (1) US5665380A (de)
EP (1) EP0734251B1 (de)
JP (1) JPH09510433A (de)
AU (1) AU680996B2 (de)
CA (1) CA2177695C (de)
DE (1) DE69435244D1 (de)
WO (1) WO1995016437A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387373B1 (en) * 1993-01-15 2002-05-14 Novavax, Inc. Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
FR2751222B1 (fr) * 1996-07-16 1998-10-09 Capsulis Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
GB9624536D0 (en) * 1996-11-26 1997-01-15 Univ Strathclyde Non-ionic surfactant vesicles as a delivery agent for nucleic acid
US5827533A (en) 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US6395305B1 (en) * 1997-09-22 2002-05-28 University Of Guelph Reduction of sperm sensitivity to chilling
US6221425B1 (en) 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
EP1304103B1 (de) * 2001-10-22 2008-12-31 Viroblock SA Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen
AU2003233464A1 (en) * 2002-03-29 2003-10-13 Bristol-Myers Squibb Corporation Lipid mediated screening of drug candidates for identification of active compounds
WO2004004635A2 (en) * 2002-07-02 2004-01-15 Board Of Regents, The University Of Texas System Radiolabeled compounds and liposomes and their methods of making and using the same
US20040087564A1 (en) * 2002-10-31 2004-05-06 Wright D. Craig Delivery composition and method
US6969702B2 (en) * 2002-11-20 2005-11-29 Neuronova Ab Compounds and methods for increasing neurogenesis
US20050209142A1 (en) * 2002-11-20 2005-09-22 Goran Bertilsson Compounds and methods for increasing neurogenesis
DE60335743D1 (de) * 2002-11-20 2011-02-24 Neuronova Ab Verbindungen und verfahren zur erhöhung der neurogenese
CN102293746A (zh) * 2003-09-09 2011-12-28 吉里德科学公司 治疗性脂质体
JP4394916B2 (ja) * 2003-09-19 2010-01-06 独立行政法人科学技術振興機構 人工脂質二重膜の形成装置および人工脂質二重膜の形成方法、並びにその利用
US20080045575A1 (en) * 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
ES2590812T3 (es) 2006-05-19 2016-11-23 Viroblock Sa Composición para inactivar un virus con envuelta
US10251839B2 (en) * 2008-01-22 2019-04-09 Igi Laboratories, Inc. Lipid vesicles derived from olive oil fatty acids
JP2012509932A (ja) * 2008-11-26 2012-04-26 ビロブロック エスアー 非リン脂質脂質小胞を使用してグラム陽性菌を抑制する方法
JP6190132B2 (ja) * 2013-03-21 2017-08-30 学校法人近畿大学 遺伝子試料導入用基板及び遺伝子試料導入方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN110128543A (zh) * 2019-04-01 2019-08-16 上海交通大学 一种仿病毒囊泡及其制备方法以及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
US4217344A (en) * 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US4917951A (en) * 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
US5147723A (en) 1987-07-28 1992-09-15 Micro-Pak, Inc. Paucilamellar lipid vesicles
US4895452A (en) 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5032457A (en) 1988-03-03 1991-07-16 Micro Vesicular Systems, Inc. Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen
ES2073777T3 (es) * 1990-10-09 1995-08-16 Vestar Inc Inhibicion de la replicacion virica.
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
GB9207731D0 (en) * 1992-04-07 1992-05-27 Proteus Molecular Design Improvements in or relating to vaccines

Also Published As

Publication number Publication date
AU1438395A (en) 1995-07-03
WO1995016437A1 (en) 1995-06-22
CA2177695A1 (en) 1995-06-22
US5665380A (en) 1997-09-09
EP0734251B1 (de) 2009-10-14
AU680996B2 (en) 1997-08-14
CA2177695C (en) 2008-05-20
EP0734251A1 (de) 1996-10-02
JPH09510433A (ja) 1997-10-21

Similar Documents

Publication Publication Date Title
DE69435244D1 (de) Verfahren zur übertragung eines biologisch aktiven materials an eine zelle
DE69229699D1 (de) Verfahren zur Herstellung eines Anodenmaterials und einer dieses Anodenmaterial verwendenden nicht wässrigen electrochemischen Zelle
DE69702482T2 (de) Verfahren zur schnellen säurehydrolyse eines lignocellulosischen materials und hydrolysereaktor
DE69430054D1 (de) Verfahren zum einbetten von tierkulturzellen
DE3854996T2 (de) Anlage und Verfahren zur Zellbildverarbeitung
DE59309088D1 (de) Herstellung von heterodimerem pdgf-ab mit hilfe eines bicistronischen vektorsystems in säugerzellen
DE69002937D1 (de) Material und verfahren zur sauerstoffabtastung.
AU7878891A (en) Improved method and apparatus for introducing biological substances into living cells
BG36073A1 (en) Method for introducing biologically active substances in plants
DE69701411D1 (de) Batterien und Verfahren zur Herstellung eines positiven aktiven Materials
DE59609706D1 (de) Verfahren zur Isolierung eines biologischen Materials
DE69614569D1 (de) Verfahren zur vermehrung von pflanzenmaterial
DE59406145D1 (de) Verfahren zur gewinnung von adsorptionsmaterial
DE68913303T2 (de) Verfahren zur kontinuierlichen trocknung eines materials.
DE3882403T2 (de) Nichtlineares optisches Material und Verfahren zu dessen Orientierung.
DE69527088T2 (de) Tierkotbehandlungsmaterial und verfahren zu dessen herstellung
IS3514A7 (is) Aðferð til að vinna líffræðilega virk efni
AU649225B2 (en) A method and apparatus for inserting material into biological cells
BR9608050A (pt) Processo para fazer um material de poliuretano celular material de poliuretano celular uso de um sal de alcanolamina e uso de um sal de trietanol-amina de ácidos graxos polimerizados
DE69033330D1 (de) Nichtwässrige elektrochemische Zelle und Verfahren zu deren Herstellung
DE69421238D1 (de) Verfahren zur herstellung einer zelle
DE69607820D1 (de) Elektrochemische zelle und elektrochemisches verfahren in einer kohlendioxidsatmosphäre
AT385061B (de) Verfahren zur gewinnung von zellstoff aus pflanzenfasermaterial
DE69229915D1 (de) Verfahren zur herstellung von magnetostriktivem material
ATA271788A (de) Verfahren zum kontinuierlichen abbau von material sowie mobile brecheranlage zur durchfuehrung dieses verfahrens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition